San Diego-centered Viking Therapeutics marked by itself as a significant competitor within the weight loss drug sector in February soon after revealing promising info from a mid-stage trial of experimental drug VK2735, which recommended it rivaled—and outperformed—Novo and Lilly drugs when specified to be a weekly injection and in March the com